About Innovative Therapeutix
Innovative Therapeutix is a private company based in Louisville, Kentucky. It has reported $210,000 raised in two offerings on Form D since February 2022. Its chief executive is Michael Detmer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 2022 | Jan 5, 2023 | $40,000fully sold | 1 | $40,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 14, 2021 | Feb 2, 2022 | $170,000of $600K target | 7 | $24,286 | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $210,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Innovative Therapeutix's Form D filed Jan 5, 2023.
RS
Robert Saunders
Director
RG
Rebekah Gossom
Director
MD
Michael Detmer
Chief Executive Officer and director